UK-356202

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameUK-356202

Drug Alias NameUK-356202

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUrokinase plasminogen activator inhibitors

TargetsUrokinase plasminogen activator

Therapy Area/IndicationsSkin UlcerVascular DiseasesNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsSkin UlcerVascular DiseasesNeoplasm Metastasis

ATC CodeN/A